Mass General's Rheumatology Unit provides cutting-edge treatment and transformative care to patients with rheumatic disease and autoimmune conditions.
Expert Care for Rheumatic Diseases
Rheumatology Associates is part of the Mass General Division of Rheumatology, Allergy and Immunology. U.S. News & World Report ranks our clinicians sixth in the nation for their expertise in evaluating and managing conditions such as:
We can also refer patients to clinicians from related specialties throughout Mass General, which is important because rheumatologic conditions typically affect multiple organs.
Members of our team are known nationally for their clinical and research leadership, including:
- Andrew Luster, MD, PhD, chief, Division of Rheumatology, Allergy and Immunology (lupus and rheumatoid arthritis)
- Marcy Bolster, MD (osteoporosis and scleroderma)
- Dwight Robinson, MD (general rheumatology)
- Allen Steere, MD, director of translational research in rheumatology (Lyme disease)
- John Stone, MD, MPH, clinical director of rheumatology (lupus and vasculitis)
Access to World-Class Services
Our unit is headquartered in the Yawkey Building on the main Mass General campus. Patients enjoy easy access to an infusion unit, X-ray facilities, laboratory facilities, and physical and occupational therapy. On arthritis cases, we often consult with the hospital's renowned hand surgeons, who also occupy our floor.
Many of our services are available at Mass General West in Waltham and at Mass General health centers in Charlestown and Chelsea.
Leadership in Research & Education
The Rheumatology Unit was established in the 1930s by Walter Bauer, MD, one of the country's first rheumatologists. Dr. John Stone has served as clinical director of rheumatology since 2008, while Dr. Andrew Luster has been division chief since 2000.
Today, an impressive range of research studies takes place within our division and our unit. Scientists in the Center for Immunology and Inflammatory Diseases conduct basic research in the mechanisms of immune-mediated inflammatory diseases. Through the Rheumatology Clinical Research Unit, patients can participate in clinical trials of novel therapies for lupus, rheumatoid arthritis, IgG4-related systemic disease and osteoarthritis.
As part of an elite teaching hospital, the Rheumatology Unit is committed to preparing the next generation of leading academic physicians, scientists and clinician-educators. Our fellowship program, affiliated with Harvard Medical School, entails intensive study of the clinical, diagnostic, therapeutic, pathogenic and research aspects of rheumatologic diseases.